|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.260 USD | -59.35% |
|
-.--% | - |
| 17/12 | Sonnet BioTherapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended September 30, 2025 | CI |
| 03/12 | Top Midday Decliners | MT |
Performance
| 1 day | -59.35% | ||
| 1 year | +6.78% | ||
| 3 years | -98.81% | ||
| 5 years | -99.97% |
Volumes
marketsDaily volume
1,04,56,154
Estimated daily volume
1,04,56,154
Record volume 1
12,98,73,699
Record volume 2
4,98,67,223
Record volume 3
4,46,15,724
Capital turnover ratio
0
Basic data
Market Cap (USD)
86,02,463
Net sales ()
1
Number of employees
9
Sales / Employee ()
0
Sales / Employee (USD)
0
Indicators
Moving average 5 days
3.279
Moving average 100 days
4.488
Price spread / (MMA5)
+160.24%
Price spread / (MMA100)
+256.17%
STIM
RSI 9 days
0
RSI 14 days
0
Historical Quotes: Sonnet Biotherapeutics
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 year | 1.1 |  | 19.3 |
| 3 years | 1.08 | | 211.2 |
| 5 years | 1.08 | | 5,100.48 |
| 10 years | 1.08 | | 39,916.83 |
Monthly variations
Annual variations
| 2025 | -13.70% | ||
| 2024 | -89.51% | ||
| 2023 | -93.12% | ||
| 2022 | -80.12% | ||
| 2021 | -81.48% | ||
| 2020 | -64.69% |
- Stock Market
- Stocks
- SONN Stock
- Quotes Sonnet Biotherapeutics
Select your edition
All financial news and data tailored to specific country editions
